Leibner Donald N MD is categorized under Internal Medicine Doctors in East Brunswick, NJ and active since 1996.
Leibner Donald N MD was established in 1996, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Donald Leibner at the company’s single location by writing to 579a Cranbury Road # 103, East Brunswick, New Jersey NJ 08816 or by phoning (732) 390-4900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Leibner Donald N MD |
| Contact Person: | Donald Leibner |
| Address: | 579a Cranbury Road # 103, East Brunswick, New Jersey 08816 |
| Phone Number: | (732) 390-4900 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1996 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Leibner Donald N MD was started in 1996 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Donald Leibner for inquiries that concern Leibner Donald N MD by calling the company number (732) 390-4900, as your correspondence is most welcome. Additionally, the physical location of the single location of Leibner Donald N MD can be found at the coordinates 40.41188,-74.41806 as well as the street address 579a Cranbury Road # 103 in East Brunswick, New Jersey 08816.
For its online presence, you may visit Leibner Donald N MD’s website at and engage with its social media outlets through on Twitter and on Facebook.